Health Tech (Hit) 2026: HIT Investing Outlook for Growth
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesQ1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...
A new retirement study finds a majority of Americans believe a 401(K) balance is enough for retirement, while nearly ...
With rates going higher, investors seek dependable income. This story highlights four dividend stocks across core sec...
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
CoreWeave faced a sharp move after its latest earnings, with shares slipping in after-hours trading despite a top-lin...
Five Buy-rated stocks from Bank America’s US1 list are highlighted for their steady dividends and potential upside. W...